← Leaderboards
Fahumiya Samad
La Jolla Inst For Molecular Medicine
$5,609,935
Attributed
$7,598,513
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $786.1K · FY2005–22$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,598,513 · 3
By mechanism
R01$7,598,513 · 3
Top collaborators
- Lindsey A Miles4 shared
- Robert J Parmer4 shared
Most similar at La Jolla Inst For Molecular Medicine
Same institution · by research overlap
- Barbara M Mueller$3,048,570
Others in their field
Top investigators on “Adipose Tissue”
- Philipp E Scherer · Ut Southwestern Medical Center$35,623,350
- Michael D. Jensen · Mayo Clinic Coll Of Medicine, Rochester$25,247,651
- C Ronald Kahn · Joslin Diabetes Center$24,965,457
- Laura E. Nagy · Case Western Reserve University$24,173,122
- Hei Sook Sul · University Of California Berkeley$23,973,403
- Ziad Nahas · Medical University Of South Carolina$22,722,368
Research focus
Adipose TissueObesityAdipocytesGene ExpressionMediatingCardiovascular DiseasesPathway InteractionsWeightIn VitroPlayMetabolismProteinsLipid BiosynthesisMacrophageInsulin ResistanceNon-Insulin-Dependent Diabetes MellitusDietInflammationInsightInnovationResponseMetabolicLipidsLink
Grant awards (14)
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$732,257
R01 · FY2022 · HL
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$732,257
R01 · FY2021 · HL
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$732,257
R01 · FY2020 · HL
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis$786,096
R01 · FY2019 · HL
Therapeutic Opportunities of Targeting Tissue Factor Signaling in Obesity$622,718
R01 · FY2014 · HL · contact PI
Therapeutic Opportunities of Targeting Tissue Factor Signaling in Obesity$575,680
R01 · FY2013 · HL · contact PI
Therapeutic Opportunities of Targeting Tissue Factor Signaling in Obesity$608,277
R01 · FY2012 · HL · contact PI
Therapeutic Opportunities of Targeting Tissue Factor Signaling in Obesity$619,081
R01 · FY2011 · HL · contact PI
Ceramide and cardiovascular risk in obesity$388,286
R01 · FY2008 · HL · contact PI
Ceramide and cardiovascular risk in obesity$388,286
R01 · FY2007 · HL · contact PI
Ceramide and cardiovascular risk in obesity$345,142
R01 · FY2006 · HL · contact PI
Ceramide and cardiovascular risk in obesity$110,326
R01 · FY2006 · HL · contact PI
Ceramide and cardiovascular risk in obesity$466,425
R01 · FY2005 · HL
Ceramide and cardiovascular risk in obesity$491,425
R01 · FY2004 · HL